Chongqing Pharscin Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced total revenue was CNY 435.735 million compared to CNY 379.486 million a year ago. Operating income was CNY 66.192 million compared to CNY 74.452 million a year ago. Net income was CNY 56.268 million compared to CNY 62.831 million a year ago. Basic earnings per share from continuing operations was CNY 0.1404 compared to CNY 0.1571 a year ago.